ProfileGDS5822 / ILMN_2732438
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 35% 9% 22% 19% 37% 49% 28% 30% 15% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.835
GSM1276600PDAC Late Ablation Control 211.59
GSM1276601PDAC Late Ablation Control 37.322
GSM1276602PDAC Late Ablation 111.219
GSM1276603PDAC Late Ablation 217.537
GSM1276604PDAC Late Ablation 323.649
GSM1303940PDAC Late Ablation_anti-CTLA4 114.828
GSM1303941PDAC Late Ablation_anti-CTLA4 214.830
GSM1303942PDAC Late Ablation_anti-CTLA4 38.715